The Correlation Between Female Age and Ovarian Reserve Biomarkers (FSH & AMH) and Its' Effect on The Response to Controlled Ovarian Hyper-stimulation (COS) and Pregnancy Rate Following Intracytoplasm sperm injection ( ICSI )

Several methods are developing to assess the biological and functional age of women ovary. Since ovarian reserve (OR) may change over time, limited ovarian reserve needs further tests to be confirmed. The likelihood of sub -fertility treatment success is highly dependent on the women’s age. With advanced age, the likelihood of having a child decreases significantly making those women in high need of assisted conception. The study aimed to assess the association between female age, ovarian reserve biomarkers (follicular stimulating hormone and anti-mullerian hormone), response to controlled ovarian stimulation (COS) represented by the dose of gonadotropin stimulation, number and quality of retrieved oocytes, cycle cancellation rate and pregnancy rate in thos e who undergo ICSI. One hundred twenty six couples complained of sub-fertility collected from Al-Kafeel Fertility and IVF Center/ Holy Kerbala/ Iraq throughout a period between 2016-2019. These couples have been evaluated and subjected to COS/ICSI and divided into two groups below and above 35 years old. Assessment of cycle day 2 FSH and AMH, response to COS, cycle cancellation rate, and the pregnancy rate has been performed, and the results compared between both. The study showed that baseline serum level of FSH and AMH did not differ between women older and younger than 35 years old (in younger women, mean serum FSH 6.6±4.0 and AMH 2.4±1.8 vs 7.7±4.3 and 2.2±2.8 respectively in older ones, p-value=0.15). Women older than 35 years old needed significantly higher doses of gonadotropin stimulation(mean total dose of r-FSH 2179.4±1222.2 vs 1987.2±947.6, p-value=0.036 and mean total dose of HMG 3122.3±1456.8 vs 2468.7±1454.8, p-value=0.02), produced significantly lower number of oocytes (6.09±4.7 vs 9.8±6.4,p-value=0.0001), lower number of mature oocytes (4.4±3.8 vs 6.7±5.1,p-value=0.005), higher rate of cycle cancellation(17.7% vs 4.6%) and insignificantly lower pregnancy rate(23.5% vs 37.7%, p-value=0.107) following ICSI in comparison with those younger than 35 years old. Age is a significant determinant factor that affects the ovarian reserve, can lead to ovarian aging, and lower the women’s fertility rate. There is a weak correlation between age, FSH, and AMH levels. Older women exhibit a low response to ovarian stimulation with a higher cancellation rate, produce a small number of oocytes with low quality following COS despite their higher need for large doses of gonadotropin stimulation. The pregnancy rate is affected by advanced women’s age following ICSI.

PDF

___

1. Balasch J. Ageing and infertility: an overview. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 2010; 26: 855- 860.
2. Bancsi L. F. J. M. M., Broekmans, F. J. M., Eijkemans, M. J. C., de Jong, F. H., Habbema, J. D. F., & te Velde, E. R. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertility and Sterility 2002; 77: 328-336.
3. Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update 2006; 12: 685-718.
4. de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002). Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertility and Sterility 2002; 77: 357-362.
5. Denny S, David K. Evaluation of embryo quality, analysis of morphology and physiology. In: Textbook of assisted reproductive techniques. David K. and Colin M. (eds.).5th ed. CRC Press Taylor & Francis Group 2018; 225-242.
6. Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. Th. J., Grootegoed, J. A., & Themmen, A. P. N. Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. Endocrinology 2001; 142: 4891-4899.
7. Eldar-Geva, T., Ben-Chetrit, A., Spitz, I. M., Rabinowitz, R., Markowitz, E., Mimoni, T., Gal, M., Zylber-Haran, E., & Margalioth, E. J. (2005). Dynamic assays of inhibin B, antiMullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Human reproduction (Oxford, England), 20(11), 3178–3183. https://doi.org/10.1093/humrep/dei203.
8. Gnoth, C., Maxrath, B., Skonieczny, T., Friol, K., Godehardt, E., & Tigges, J. (2011). Final ART success rates: a 10 years survey. Human Reproduction (Oxford, England), 26(8), 2239– 2246. https://doi.org/10.1093/humrep/der178.
9. Hansen, K. R., Knowlton, N. S., Thyer, A. C., Charleston, J. S., Soules, M. R., & Klein, N. A. (2008). A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Human reproduction (Oxford, England), 23(3), 699– 708. https://doi.org/10.1093/humrep/dem408.
10. Hussein, M., Alalaf, S., & Al-Tawil, N. (2018). Effect of maternal age on the ovarian reserve markers, and pregnancy outcome in a sample of Kurdish women in Erbil city. Zanco Journal of Medical Sciences, 22(1), 8–16. https://doi.org/10.15218/zjms.2018.002.
11. Irit G, Nava D (2018). Preparation and evaluation of oocytes for intracytopsmic sperm injection. In : Textbook of assisted reproductive techniques. David K. and Colin M. (eds.).5th ed. CRC Press Taylor & Francis Group.,108-116.
12. Karim, S. (2018). The effect of maternal age on the outcomes of in vitro fertilization Sulaimani region. Mustansiriya Medical Journal, 15(1), 5. Retrieved from http://mmj.uomustansiriyah.edu.iq/inde x.php/MMJ/article/view/273
13. Lee, T.-H., Liu, C.-H., Huang, C.-C., Hsieh, K.- C., Lin, P.-M., & Lee, M.-S. (2009). Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles. Reproductive Biology and Endocrinology, 7(1). https://doi.org/10.1186/1477-7827-7-100.
14. Lekamge, D. N., Barry, M., Kolo, M., Lane, M., Gilchrist, R. B., & Tremellen, K. P. (2007). Anti- Müllerian hormone as a predictor of IVF outcome. Reproductive BioMedicine Online, 14(5), 602–610. https://doi.org/10.1016/s1472- 6483(10)61053-x.
15. Liu, K., Case, A., Cheung, A. P., Sierra, S., AlAsiri, S., Carranza-Mamane, B., Case, A., Dwyer, C., Graham, J., Havelock, J., Hemmings, R., Lee, F., Liu, K., Murdock, W., Senikas, V., Vause, T. D. R., & Wong, B. C.- M. (2011). Advanced Reproductive Age and Fertility. Journal of Obstetrics and Gynaecology Canada, 33(11), 1165–1175. https://doi.org/10.1016/s1701- 2163(16)35087-3.
16.Maheshwari, A., Fowler, P., & Bhattacharya, S. (2006). Assessment of ovarian reserve, should we perform tests of ovarian reserve routinely? Human Reproduction, 21(11), 2729– 2735. https://doi.org/10.1093/humrep/del188.
17. Muttukrishna, S., McGarrigle, H., Wakim, R., Khadum, I., Ranieri, D. M., & Serhal, P. (2005). Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG: An International Journal of Obstetrics & Gynaecology, 112(10), 1384– 1390. https://doi.org/10.1111/j.1471- 0528.2005.00670.x.
18. Nelson, S. M. (2013). Biomarkers of ovarian response: current and future applications. Fertility and Sterility, 99(4), 963– 969. https://doi.org/10.1016/j.fertnstert.2012.11.0 51.
19. Penzias, A., Azziz, R., Bendikson, K., Falcone, T., Hansen, K., Hill, M., Hurd, W., Jindal, S., Kalra, S., Mersereau, J., Racowsky, C., Rebar, R., Reindollar, R., Shannon, C. N., Steiner, A., Stovall, D., Tanrikut, C., Taylor, H., &
20. Yauger, B. (2020). Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility, 114(6), 1151– 1157. https://doi.org/10.1016/j.fertnstert.2020.09.1 34.
21. Thum, M.-Y., Abdalla, H. I., & Taylor, D. (2008). Relationship between women’s age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment. Fertility and Sterility, 90(2), 315– 321. https://doi.org/10.1016/j.fertnstert.2007.06.0 63.
22. Van Rooij, I. A. J. (2002). Serum antiMullerian hormone levels: a novel measure of ovarian reserve. Human Reproduction, 17(12), 3065–3071. https://doi.org/10.1093/humrep/17.12.3065.
23. Van Rooij, I. A., Broekmans, F. J., Hunault, C. C., Scheffer, G. J., Eijkemans, M. J., de Jong, F. H., Themmen, A. P., & te Velde, E. R. (2006). Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility. Reproductive biomedicine online, 12(2), 182–190. https://doi.org/10.1016/s1472- 6483(10)60859-0.
24. Weenen, C., Laven, J. S., Von Bergh, A. R., Cranfield, M., Groome, N. P., Visser, J. A., Kramer, P., Fauser, B. C., & Themmen, A. P. (2004). Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular human reproduction, 10(2), 77–83. https://doi.org/10.1093/molehr/gah015.
25. Yan, J., Wu, K., Tang, R., Ding, L., & Chen, Z.-J. (2012). Effect of maternal age on the outcomes of in vitro fertilization and embryo transfer (IVF-ET). Science China Life Sciences, 55(8), 694–698. https://doi.org/10.1007/s11427-012-4357-0.